跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
趙 瑞益
教授
分子醫學與生物工程研究所
智慧型藥物與智能生物裝置研究中心
https://orcid.org/0000-0001-7671-3072
h-index
h10-index
h5-index
3287
引文
27
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
343
引文
9
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
59
引文
5
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1996 …
2025
每年研究成果
概覽
指紋
網路
計畫
(27)
研究成果
(79)
獎項
(1)
活動
(1)
類似的個人檔案
(6)
指紋
查看啟用 Jui-I Chao 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Nanodiamond
95%
Survivin
77%
Apoptosis
70%
Securin
68%
Cytotoxicity
60%
Colorectal Cancer Cells
57%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
53%
Cancer Cells
49%
Induced Apoptosis
40%
Human Colorectal Cancer
39%
Paclitaxel
36%
Carboxylated Nanodiamond
35%
Oxaliplatin
33%
Fluorescent Nanodiamonds
33%
Epidermal Growth Factor Receptor
32%
Cadmium
31%
Protein Expression
30%
Tumor Inhibition
30%
P53 Pathway
30%
Autophagy Receptor
28%
Cancer Cell Death
28%
Cancer Therapy
27%
Survivin Protein
27%
Biocompatibility
27%
Human Lung Carcinoma Cells
25%
Cdc2
22%
Mitotic Catastrophe
21%
Phosphorylation
21%
Cell Growth Inhibition
21%
Cetuximab
21%
Growth Inhibition
20%
Protein Level
20%
H2AX
20%
Lung Carcinoma Cells
20%
Drug Delivery
20%
Blockage
20%
Biolabeling
20%
SQSTM1
20%
Selective Autophagy
19%
Celecoxib
19%
Anticancer Activity
19%
Nanoparticles
18%
Cell Migration
18%
Gefitinib
18%
Chloro
18%
Human Lung Cancer
18%
Cell Death
18%
Breast Cancer
18%
Arsenite (AsIII)
18%
Cell Growth
17%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Colorectal Carcinoma
92%
Survivin
86%
Protein P53
80%
Securin
68%
Nanodiamond
67%
Cytotoxicity
56%
Mitogen Activated Protein Kinase P38
47%
Lung Cancer
46%
Paclitaxel
44%
Epidermal Growth Factor Receptor
42%
Lung Carcinoma
42%
Oxaliplatin
33%
Cancer Inhibition
29%
Nanoparticle
26%
Gefitinib
25%
Carcinogenesis
23%
Receptor
21%
Neoplasm
21%
Cetuximab
21%
Non Small Cell Lung Cancer
19%
Phosphotransferase
19%
Celecoxib
19%
Colon Carcinoma
18%
Breast Cancer
18%
Arsenous Acid
17%
Arsenite
17%
Chinese Hamster
16%
Reactive Oxygen Metabolite
16%
Nitric Oxide
16%
Baicalein
16%
Sequestosome 1
16%
Caspase 3
16%
Tumor Growth
13%
Catalase
12%
Amitrole
12%
Proteasome
12%
Nanomaterial
12%
Confocal Microscopy
11%
Breast Tumor
11%
Combination Therapy
11%
Cell Viability
10%
S-Nitroso-N-Acetylpenicillamine
10%
Anticancer Drug
10%
Nude Mouse
9%
Quercetin
9%
Mutagenicity
9%
Diseases
9%
Nanocomposite
9%
Cardiovascular Disease
9%
